Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates
Abstract To study the relationship between the delay in treatment and the efficacy of phenobarbital in neonates, we re‐analyzed data from the NEOLEV2 study. Continuous video EEG (cEEG) from patients treated with phenobarbital was reviewed by neurophysiologists who marked each seizure. The time from...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Epilepsia Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/epi4.70020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690541654016000 |
|---|---|
| author | Cynthia Sharpe Charlotte‐Rose Rennie‐Younger Dug Yeo Han Suzanne L. Davis Mark Nespeca Francesco Pisani Jeffrey J. Gold Gail E. Reiner Sonya Wang Richard H. Haas |
| author_facet | Cynthia Sharpe Charlotte‐Rose Rennie‐Younger Dug Yeo Han Suzanne L. Davis Mark Nespeca Francesco Pisani Jeffrey J. Gold Gail E. Reiner Sonya Wang Richard H. Haas |
| author_sort | Cynthia Sharpe |
| collection | DOAJ |
| description | Abstract To study the relationship between the delay in treatment and the efficacy of phenobarbital in neonates, we re‐analyzed data from the NEOLEV2 study. Continuous video EEG (cEEG) from patients treated with phenobarbital was reviewed by neurophysiologists who marked each seizure. The time from seizure onset to phenobarbital, total seizure burden pre‐phenobarbital, and maximum seizure density (summed seizure burden per hour) pre‐phenobarbital were calculated and correlated with phenobarbital efficacy at 20 mg/kg and at 40 mg/kg. The time between seizure onset and phenobarbital treatment did not predict refractoriness to phenobarbital. However, the maximum seizure density per hour and total seizure burden before phenobarbital treatment were strongly correlated with efficacy. ROC curve analysis showed cut‐offs of maximum seizure density pre‐phenobarbital of 10 ½ min/h and total seizure burden pre‐phenobarbital of 36 ¼ min had excellent discriminatory ability in separating patients in whom phenobarbital would be effective from patients in whom it would not be effective (AUC 0.84, p = 0.0002 and AUC 0.85, p = 0.0051). These data suggest that whereas neonates with high seizure density must be treated as an emergency, mild‐to‐moderate seizures remain responsive to phenobarbital if treated within a time frame of several hours. Plain Language Summary Phenobarbital is very effective at stopping seizures in newborns. But if phenobarbital is given after many hours of seizures, it becomes less effective. We do not know how quickly this happens. Our study found that it does not happen over the short term (<4 h). It is more difficult to stop seizures that cumulatively last more than 10 min/h. |
| format | Article |
| id | doaj-art-ffa663a5ad4d4238a75b41c26f11a01d |
| institution | DOAJ |
| issn | 2470-9239 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Epilepsia Open |
| spelling | doaj-art-ffa663a5ad4d4238a75b41c26f11a01d2025-08-20T03:21:17ZengWileyEpilepsia Open2470-92392025-06-0110394895610.1002/epi4.70020Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonatesCynthia Sharpe0Charlotte‐Rose Rennie‐Younger1Dug Yeo Han2Suzanne L. Davis3Mark Nespeca4Francesco Pisani5Jeffrey J. Gold6Gail E. Reiner7Sonya Wang8Richard H. Haas9Department of Paediatric Neurology Starship Children's Health Auckland New ZealandDepartment of Paediatric Neurology Starship Children's Health Auckland New ZealandStarship Research and Innovation Starship Foundation Auckland New ZealandDepartment of Paediatric Neurology Starship Children's Health Auckland New ZealandDepartment of Neurosciences University of California San Diego, Rady Children's Hospital San Diego San Diego California USADepartment of Neuroscience Sapienza University Rome ItalyDepartment of Neurosciences University of California San Diego, Rady Children's Hospital San Diego San Diego California USADepartment of Neurosciences University of California San Diego, Rady Children's Hospital San Diego San Diego California USADepartment of Pediatric Neurology University of Minnesota School of Medicine Minneapolis Minnesota USADepartment of Neurosciences University of California San Diego, Rady Children's Hospital San Diego San Diego California USAAbstract To study the relationship between the delay in treatment and the efficacy of phenobarbital in neonates, we re‐analyzed data from the NEOLEV2 study. Continuous video EEG (cEEG) from patients treated with phenobarbital was reviewed by neurophysiologists who marked each seizure. The time from seizure onset to phenobarbital, total seizure burden pre‐phenobarbital, and maximum seizure density (summed seizure burden per hour) pre‐phenobarbital were calculated and correlated with phenobarbital efficacy at 20 mg/kg and at 40 mg/kg. The time between seizure onset and phenobarbital treatment did not predict refractoriness to phenobarbital. However, the maximum seizure density per hour and total seizure burden before phenobarbital treatment were strongly correlated with efficacy. ROC curve analysis showed cut‐offs of maximum seizure density pre‐phenobarbital of 10 ½ min/h and total seizure burden pre‐phenobarbital of 36 ¼ min had excellent discriminatory ability in separating patients in whom phenobarbital would be effective from patients in whom it would not be effective (AUC 0.84, p = 0.0002 and AUC 0.85, p = 0.0051). These data suggest that whereas neonates with high seizure density must be treated as an emergency, mild‐to‐moderate seizures remain responsive to phenobarbital if treated within a time frame of several hours. Plain Language Summary Phenobarbital is very effective at stopping seizures in newborns. But if phenobarbital is given after many hours of seizures, it becomes less effective. We do not know how quickly this happens. Our study found that it does not happen over the short term (<4 h). It is more difficult to stop seizures that cumulatively last more than 10 min/h.https://doi.org/10.1002/epi4.70020continuous EEG monitoringhypoxic ischemic encephalopathyneonatal seizuresphenobarbitalseizure |
| spellingShingle | Cynthia Sharpe Charlotte‐Rose Rennie‐Younger Dug Yeo Han Suzanne L. Davis Mark Nespeca Francesco Pisani Jeffrey J. Gold Gail E. Reiner Sonya Wang Richard H. Haas Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates Epilepsia Open continuous EEG monitoring hypoxic ischemic encephalopathy neonatal seizures phenobarbital seizure |
| title | Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates |
| title_full | Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates |
| title_fullStr | Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates |
| title_full_unstemmed | Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates |
| title_short | Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates |
| title_sort | efficacy of phenobarbital is maintained after exposure to mild to moderate seizures in neonates |
| topic | continuous EEG monitoring hypoxic ischemic encephalopathy neonatal seizures phenobarbital seizure |
| url | https://doi.org/10.1002/epi4.70020 |
| work_keys_str_mv | AT cynthiasharpe efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT charlotteroserennieyounger efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT dugyeohan efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT suzanneldavis efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT marknespeca efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT francescopisani efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT jeffreyjgold efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT gailereiner efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT sonyawang efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates AT richardhhaas efficacyofphenobarbitalismaintainedafterexposuretomildtomoderateseizuresinneonates |